News archive.
Earlier AI news and analysis, kept for reference. Current coverage lives in News & Analysis.
Upper GI Cancer Misses Hit 8% — AI Landmarks Can Help
Combined endoscopy procedures are now routine, but upper GI quality standards lag far behind colonoscopy. AI landmark verification offers a path to catch what endoscopists miss.
Physicians want schedule control, not better AI scribes
Ambient documentation tools reduce charting burden, but hospitals reallocate freed time to more patients. McKinsey data shows 66% of physicians dissatisfied with schedules report burnout—far higher than those logging long hours on their own terms.
Neumora depression drug fails; biotech cuts 50% of staff
Neumora's failed depression treatment marks another setback for brain-focused biotech. The company is cutting half its workforce as the field faces repeated clinical disappointments.
Jazz licenses AbCellera's T cell tech in $4B deal
Jazz Pharmaceuticals and AbCellera struck a multi-billion dollar partnership to expand T cell engagers beyond blood cancers, where the approach has so far seen limited clinical wins.
UniQure files gene therapy as FDA leadership signals shift on approvals
UniQure's filing comes after two senior FDA officials departed, suggesting the agency may be willing to greenlight therapies it previously rejected. What changed at the regulator.
Four biotech IPOs topped $400M in 2026, highest pace since 2021
Kardigan's heart drug unit raised $400M this week, joining three peers in a biotech IPO rebound. Here's what the capital surge signals about investor appetite.
Surgeon's microsurgery robot gives steadier hands than human control
MMI built a robot to help surgeons perform microsurgical procedures with greater precision than the human hand alone allows. Here's what the system does and who benefits.
Medtech M&A surges past 2025 record with Boston Scientific, Danaher deals
Medtech deal volumes and values are outpacing the first half of 2025, driven by major acquisitions including Boston Scientific's Penumbra buyout and Danaher's Masimo acquisition. Here's what the trend signals for the sector.
FDA warns breast biopsy needle shortage extends to 2027
The FDA says shortages of certain breast biopsy needles will persist through 2027, following Hologic's January market removal. What hospitals should expect.
Distalmotion expands Dexter robotic surgery to more gynecology procedures
Swiss robotics firm Distalmotion is adding new surgical indications for its Dexter system in the U.S. market, targeting ambulatory surgery centers seeking higher utilization rates.
Lifepoint promotes CFO Aaron Lewis to COO as health system expands
Aaron Lewis moves from CFO to chief operating officer at Lifepoint Health, signaling the system's focus on geographic expansion and service diversification.
ACA marketplace insurers drop to 9 per state as policy shifts scare carriers
Average insurer participation fell from 9.6 to 9 states in 2026, per KFF. Policy turmoil is driving carriers away from ACA exchanges—what this means for your coverage options.